Your browser doesn't support javascript.
loading
Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance.
Balkrishna, Acharya; Sharma, Sonam; Gohel, Vivek; Kumari, Ankita; Rawat, Malini; Maity, Madhulina; Sinha, Sandeep; Dev, Rishabh; Varshney, Anurag.
Afiliação
  • Balkrishna A; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
  • Sharma S; Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India.
  • Gohel V; Patanjali Yog Peeth (UK) Trust, Glasgow, United Kingdom.
  • Kumari A; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
  • Rawat M; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
  • Maity M; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
  • Sinha S; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
  • Dev R; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
  • Varshney A; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
PLoS One ; 18(11): e0293605, 2023.
Article em En | MEDLINE | ID: mdl-37939153
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vancomicina / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vancomicina / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article